Tan DSW, Felip E, de Castro G, Solomon BJ, et al. Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. J Clin Oncol 2023 Dec 1:JCO2300980. doi: 10.1200/JCO.23.00980.
PMID: 38039427